DE69738793D1 - Pharmazeutische zubereitungen - Google Patents

Pharmazeutische zubereitungen

Info

Publication number
DE69738793D1
DE69738793D1 DE69738793T DE69738793T DE69738793D1 DE 69738793 D1 DE69738793 D1 DE 69738793D1 DE 69738793 T DE69738793 T DE 69738793T DE 69738793 T DE69738793 T DE 69738793T DE 69738793 D1 DE69738793 D1 DE 69738793D1
Authority
DE
Germany
Prior art keywords
pharmaceutical preparations
independently
phosphoenolpyruvate
alky
aralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69738793T
Other languages
English (en)
Inventor
Albina Vladimirovna Dogadina
Igor Evgenyevich Gourevitch
Boris Iosifovich Ionine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ITC Research Ltd
Original Assignee
ITC Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ITC Research Ltd filed Critical ITC Research Ltd
Application granted granted Critical
Publication of DE69738793D1 publication Critical patent/DE69738793D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/113—Esters of phosphoric acids with unsaturated acyclic alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2404—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2412—Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of unsaturated acyclic alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2462—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of unsaturated acyclic amines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69738793T 1996-11-21 1997-11-21 Pharmazeutische zubereitungen Expired - Lifetime DE69738793D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9624188.0A GB9624188D0 (en) 1996-11-21 1996-11-21 Pharmaceutical formulations
PCT/GB1997/003203 WO1998022479A1 (en) 1996-11-21 1997-11-21 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
DE69738793D1 true DE69738793D1 (de) 2008-08-07

Family

ID=10803259

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69738793T Expired - Lifetime DE69738793D1 (de) 1996-11-21 1997-11-21 Pharmazeutische zubereitungen

Country Status (10)

Country Link
US (1) US6184214B1 (de)
EP (1) EP0942915B1 (de)
JP (1) JP4135984B2 (de)
AT (1) ATE399173T1 (de)
AU (1) AU737679B2 (de)
DE (1) DE69738793D1 (de)
DK (1) DK0942915T3 (de)
ES (1) ES2309994T3 (de)
GB (1) GB9624188D0 (de)
WO (1) WO1998022479A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277884B1 (en) 1998-06-01 2001-08-21 Nitromed, Inc. Treatment of sexual dysfunction with N-hydroxyguanidine compounds
US6436997B1 (en) 1998-06-01 2002-08-20 Nitromed, Inc. Endogenous nitric oxide synthesis under conditions of low oxygen tension
US7629329B2 (en) * 2001-06-04 2009-12-08 Tsi Health Sciences, Inc. Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20080125400A1 (en) * 2006-11-27 2008-05-29 Christopher Speirs Use of phosphoenolpyruvate derivatives

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3246M (fr) * 1964-02-06 1965-04-12 Pharmacodynamie Et Metabolisme Médicaments a base d'acide phospho-énol-pyruvique.
US3940458A (en) * 1972-02-29 1976-02-24 Mobil Oil Corporation 1-Carbamoyl vinyl phosphates
SE8200252L (sv) * 1982-01-18 1983-07-19 Pharmacia Ab Farmaceutisk komposition
US4874882A (en) * 1986-03-25 1989-10-17 Ube Industries, Ltd. Process for preparing monosodium phosphoenolpyruvate
JPH064656B2 (ja) * 1986-08-13 1994-01-19 宇部興産株式会社 ホスホエノ−ルピルビン酸モノナトリウム塩１水和物の製造方法
US4880786A (en) * 1987-01-14 1989-11-14 Ube Industries, Ltd. Additive solution for blood preservation and activation
US4826675A (en) 1988-02-17 1989-05-02 Colgate-Palmolive Company Anticalculus oral composition
JP2770175B2 (ja) * 1988-09-27 1998-06-25 科学技術振興事業団 腎臓の庇護液
RU2043358C1 (ru) 1992-11-24 1995-09-10 Игорь Евгеньевич Гуревич Способ получения фосфоенолпирувата
US5395822A (en) 1993-09-20 1995-03-07 Izumi; Yukitoshi Use of pyruvate to prevent neuronal degeneration associated with ischemia
US5707971A (en) * 1995-06-07 1998-01-13 Life Resuscitation Technologies, Inc. Modulation of glycolytic ATP production

Also Published As

Publication number Publication date
ES2309994T3 (es) 2008-12-16
EP0942915B1 (de) 2008-06-25
GB9624188D0 (en) 1997-01-08
AU737679B2 (en) 2001-08-30
JP2001506594A (ja) 2001-05-22
EP0942915A1 (de) 1999-09-22
US6184214B1 (en) 2001-02-06
WO1998022479A1 (en) 1998-05-28
DK0942915T3 (da) 2008-11-03
AU5062098A (en) 1998-06-10
JP4135984B2 (ja) 2008-08-20
ATE399173T1 (de) 2008-07-15

Similar Documents

Publication Publication Date Title
AU549927B2 (en) 2-oxindole-1-carboxamide derivatives
MY100947A (en) External pharmaceutical composition.
MY115679A (en) Process for preparing intermediates to florfenicol
DE69830504D1 (de) Antithrombotische mitteln
ES2121988T3 (es) Derivado de morfinano y uso medicinal.
TR199903278T2 (en) 2-Substit�te 4,5-Diaril imidazoller.
ATE72448T1 (de) 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel.
KR960705810A (ko) 퀴나졸린 유도체(quinazoline derivatives)
EA199700307A1 (ru) Циклические пептидные антигрибковые агенты
ATE399173T1 (de) Pharmazeutische zubereitungen
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
ES8704875A1 (es) Procedimiento de producir compuestos para tratar la hiper- tension
ATE296115T1 (de) Ortsspezifische arzneimittel verabreichung
ATE228359T1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
DE69405999D1 (de) Pharmazeutisch wirksame enantiomere
TR199902820T2 (xx) Multisiklik eritromisin t�revleri.
TR200002012T2 (tr) İzopropil-metil [2-(3-n-propoksifenoksi)etil] amin' in yeni bir fosfat tuzu.
BR9912888A (pt) Derivado de 3-azabiciclo [3.2.0] heptano n-substituìdo.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition